Venous Thromboembolism Prophylaxis and Risk in the Inpatient and Outpatient Continuum of Care Among Hospitalized Acutely Ill Patients in the US: A Retrospective Analysis
- PMID: 30543037
- DOI: 10.1007/s12325-018-0846-2
Venous Thromboembolism Prophylaxis and Risk in the Inpatient and Outpatient Continuum of Care Among Hospitalized Acutely Ill Patients in the US: A Retrospective Analysis
Abstract
Introduction: Venous thromboembolism (VTE) is a leading cause of preventable morbidity and mortality among hospitalized patients in the US. The objectives of this study were to examine VTE prophylaxis patterns and risk for VTE events during hospitalization and post-discharge among patients hospitalized for acute illnesses in the US.
Methods: Acutely ill hospitalized patients were identified from the MarketScan databases (January 1, 2012-June 30, 2015). Proportions of patients that received inpatient and/or outpatient VTE prophylaxis were determined. VTE rates were calculated for the overall study population and for each subpopulation with each acute illness type. Risk for VTE events after the index admission was determined by Kaplan-Meier analysis.
Results: Of the acutely ill patients (n = 17,895, mean age: 58.4 years), most were hospitalized for infectious diseases (40.6%), followed by respiratory diseases (31.0%), cancer (10.7%), heart failure (10.4%), ischemic stroke (6.4%), and rheumatic diseases (0.9%). Among the entire study population, 59.1% did not receive any VTE prophylaxis, and only 7.1% received both inpatient and outpatient prophylaxis. Among the overall study population, cumulative VTE rate, including during index admission and within 6 months post-discharge, was 4.6%. VTE risk in the inpatient and outpatient continuum of care remained elevated up to 30-40 days after hospital admission, with 60.1% of VTEs occurring within 40 days of hospital admission.
Conclusion: In this retrospective analysis of nearly 18,000 patients hospitalized for acute illnesses, 59.1% did not receive any VTE prophylaxis and only 7.1% received VTE prophylaxis in both the inpatient and outpatient continuum of care, despite significant VTE risk extending from hospitalization into the post-discharge period.
Funding: Portola Pharmaceuticals.
Keywords: Acute illness; Cardiology; Hospitalized patients; Inpatient and outpatient continuum of care; Prophylaxis; Venous thromboembolism.
Similar articles
-
Venous Thromboembolism Prophylaxis and Risk for Acutely Medically Ill Patients Stratified by Different Ages and Renal Disease Status.Clin Appl Thromb Hemost. 2019 Jan-Dec;25:1076029618823287. doi: 10.1177/1076029618823287. Clin Appl Thromb Hemost. 2019. PMID: 30808218 Free PMC article.
-
Hospital performance for pharmacologic venous thromboembolism prophylaxis and rate of venous thromboembolism : a cohort study.JAMA Intern Med. 2014 Oct;174(10):1577-84. doi: 10.1001/jamainternmed.2014.3384. JAMA Intern Med. 2014. PMID: 25133488
-
Duration of venous thromboembolism risk across a continuum in medically ill hospitalized patients.J Hosp Med. 2012 Mar;7(3):231-8. doi: 10.1002/jhm.1002. Epub 2011 Dec 21. J Hosp Med. 2012. PMID: 22190427
-
Venous thromboembolism prophylaxis after hospital discharge: transition to preventive care.Hosp Pract (1995). 2011 Aug;39(3):7-15. doi: 10.3810/hp.2011.08.574. Hosp Pract (1995). 2011. PMID: 21881387 Review.
-
Prevention of venous thromboembolism in the hospitalized medical patient.Cleve Clin J Med. 2008 Apr;75 Suppl 3:S7-16. doi: 10.3949/ccjm.75.suppl_3.s7. Cleve Clin J Med. 2008. PMID: 18494223 Review.
Cited by
-
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: July 2021 update on postdischarge thromboprophylaxis.Blood Adv. 2022 Jan 25;6(2):664-671. doi: 10.1182/bloodadvances.2021005945. Blood Adv. 2022. PMID: 34727173 Free PMC article.
-
Formal and informal venous thromboembolism risk assessment and impact on prescribing of thromboprophylaxis: a retrospective cohort study.Int J Clin Pharm. 2023 Aug;45(4):864-874. doi: 10.1007/s11096-023-01578-w. Epub 2023 Apr 19. Int J Clin Pharm. 2023. PMID: 37074512 Free PMC article.
-
A Systematic Review of Medical Costs Associated with Heart Failure in the USA (2014-2020).Pharmacoeconomics. 2020 Nov;38(11):1219-1236. doi: 10.1007/s40273-020-00952-0. Pharmacoeconomics. 2020. PMID: 32812149 Free PMC article.
-
Influence of the duration of hospital length of stay on frequency of prophylaxis and risk for venous thromboembolism among patients hospitalized for acute medical illnesses in the USA.Drugs Context. 2019 Jan 21;8:212568. doi: 10.7573/dic.212568. eCollection 2019. Drugs Context. 2019. PMID: 30719052 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Medical